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Abstract 
Background: To prolong the effect of spinal anaesthesia into the postoperative 
period many pharmacological agents are being used intrathecally and 
intravenously. The present study was designed to evaluate  the effects of single 
bolus dose of intravenous Dexmedetomidine on spinal anaesthesia and 
analgesia in patients undergoing below umbilical surgeries under spinal 
anaesthesia with 0.5% Hyperbaric Bupivacaine. 
Methods: Sixty patients posted for below umbilical surgeries under spinal 
anaesthesia were randomly allocated to two groups. Group D (study group) 
patients received single bolus dose of 0.5mcg/kg of intravenous 
Dexmedetomidine and Group C (control group) received 100 ml of normal 
saline. Variation in the onset of sensory and motor block, two segment 
regression time , duration of  motor block, duration of analgesia, effect on 
sedation and side effects were recorded. 
Results: The onset of sensory and motor block was significantly earlier in 
Group D (2.20 ± 0.80 minutes, 2.17±0.53 minutes ) as compared to Group C 
(4.33 ± 0.84 minutes, 3.87 ± 0.62 minutes ). The two segment regression was 
significantly prolonged in Group D (104±20.6 minutes) as compared to Group 
C (75±22.5 minutes). The duration of analgesia in Group D (223.83 ± 12.64 
minutes) was significantly prolonged when compared to Group C (180.83 ± 
17.27 minutes). Sedation score and incidence of bradycardia was high in Group 
D when compared to Group C. 
Conclusion: Single bolus dose of IV Dexmedetomidine prior to spinal 
anaesthesia prolongs the duration of sensory block and duration of analgesia 
with satisfactory arousable sedation and acceptable side effects. 
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